Skip to main content
Erschienen in: Clinical Rheumatology 9/2016

07.11.2015 | Original Article

IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response

verfasst von: Mei Zeng, Wantai Dang, Baofeng Chen, Yufeng Qing, Wenguang Xie, Mingcai Zhao, Jingguo Zhou

Erschienen in: Clinical Rheumatology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Acute gouty arthritis (AGA) is an auto-inflammatory disease characterized by resolving spontaneously, which suggests that negative feedback loops control inflammatory and immunological responses to monosodium urate (MSU) crystals. By now, the molecular mechanism for spontaneous resolution of acute GA remains unclear; this study was undertaken to evaluate whether IL-37 is involved in spontaneous resolution of AGA. A total of 45 acute GA (AGA),29 non-acute GA (NAGA) male patients and 82 male health control (HC) were involved in this study, we measured IL-7 expression in the peripheral blood mononuclear cells (PBMCs), together with levels of IL-1β, IL-6, IL-10, TNF-α and TGF-β1 in the serum. Further, we either inhibited IL-37 expression in human PBMCs with siRNA or over-expressed the cytokine in human macrophages. Pro-inflammatory cytokine IL-1β, IL-6, and TNF-α expressions were significantly higher in the AGA group than in the NAGA or HC group (P < 0.05, respectively). However, anti-inflammatory IL-37, TGF-β1, and IL-10 were greater in the NAGA group than in the AGA and HC groups (P < 0.05, respectively). Expression of IL-37 in MSU crystal-treated macrophages inhibited the expression of pro-inflammatory cytokines, whereas the abundance of these cytokines increased with silencing of endogenous IL-37 in human blood cells. However, anti-inflammatory TGF-β1 and IL-10 expressions in these supernatants were unaffected by over-expression or knockdown of IL-37. Our study indicates that IL-37 is an important anti-inflammatory cytokine in AGA by suppressing the production of pro-inflammatory cytokines. Thus, IL-37 may provide a novel research target for the pathogenesis and therapy of GA.
Literatur
3.
Zurück zum Zitat Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859–1864PubMed Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859–1864PubMed
4.
Zurück zum Zitat Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 67:960–966CrossRefPubMed Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T et al (2008) Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis 67:960–966CrossRefPubMed
5.
Zurück zum Zitat Taniguchi A, Kammatani N (2008) Control of renal uric acid excretion and gout. Curr Opin Rheumatol 20:192–197CrossRefPubMed Taniguchi A, Kammatani N (2008) Control of renal uric acid excretion and gout. Curr Opin Rheumatol 20:192–197CrossRefPubMed
6.
Zurück zum Zitat Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521CrossRefPubMed Shi Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521CrossRefPubMed
7.
Zurück zum Zitat Ghaemi-Oskouie F, Shi Y (2011) The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep 13:160–166CrossRefPubMedPubMedCentral Ghaemi-Oskouie F, Shi Y (2011) The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep 13:160–166CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Cronstein BN, Terkeltaub R (2006) The inflammatory process of gout and its treatment. Arthritis Res Ther 8:S1–S3CrossRef Cronstein BN, Terkeltaub R (2006) The inflammatory process of gout and its treatment. Arthritis Res Ther 8:S1–S3CrossRef
9.
Zurück zum Zitat Ortiz-Bravo E, Sieck MS, Schumacher HR Jr (1993) Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 36:1274–1285CrossRefPubMed Ortiz-Bravo E, Sieck MS, Schumacher HR Jr (1993) Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum 36:1274–1285CrossRefPubMed
10.
Zurück zum Zitat Lioté F, Prudhommeaux F, Schiltz C, Champy R, Herbelin A, Ortiz-Bravo E et al (1996) Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1. Arthritis Rheum 39:1192–1198CrossRefPubMed Lioté F, Prudhommeaux F, Schiltz C, Champy R, Herbelin A, Ortiz-Bravo E et al (1996) Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1. Arthritis Rheum 39:1192–1198CrossRefPubMed
11.
Zurück zum Zitat Falasca GF, Ramachandrula A, Kelley KA, O’Connor CR, Reginato AJ (1993) Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 36:105–116CrossRefPubMed Falasca GF, Ramachandrula A, Kelley KA, O’Connor CR, Reginato AJ (1993) Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 36:105–116CrossRefPubMed
12.
Zurück zum Zitat Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL-1) as a mediator of crystal arthritis: stimulation of T cell and synovial fi broblast mitogenesis by urate crystalinduced IL-1. J Immunol 138(10):3213–3218PubMed Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL-1) as a mediator of crystal arthritis: stimulation of T cell and synovial fi broblast mitogenesis by urate crystalinduced IL-1. J Immunol 138(10):3213–3218PubMed
13.
Zurück zum Zitat Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M (1989) Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 83:585–592CrossRefPubMedPubMedCentral Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M (1989) Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 83:585–592CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Guerne PA, Terkeltaub R, Zuraw B, Lotz M (1989) Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32:1443–1452CrossRefPubMed Guerne PA, Terkeltaub R, Zuraw B, Lotz M (1989) Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32:1443–1452CrossRefPubMed
15.
Zurück zum Zitat Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T (1989) Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 169:291–296CrossRefPubMed Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T (1989) Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 169:291–296CrossRefPubMed
16.
Zurück zum Zitat Chen YH, Hsieh SC, Chen WY, Li KJ, Wu CH, Wu PC et al (2011) Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFβ1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3. Ann Rheum Dis 70:1655–1663CrossRefPubMed Chen YH, Hsieh SC, Chen WY, Li KJ, Wu CH, Wu PC et al (2011) Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFβ1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3. Ann Rheum Dis 70:1655–1663CrossRefPubMed
17.
Zurück zum Zitat Anna S, Francesca O, Roberta R, Frallonardo P, Dayer JM, Punzi L (2012) Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase. Ann Rheum Dis 71:621–624CrossRef Anna S, Francesca O, Roberta R, Frallonardo P, Dayer JM, Punzi L (2012) Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase. Ann Rheum Dis 71:621–624CrossRef
18.
Zurück zum Zitat Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014–1022CrossRefPubMedPubMedCentral Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11:1014–1022CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D et al (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22:127–147PubMed Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D et al (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22:127–147PubMed
21.
Zurück zum Zitat Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S et al (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18:61–71CrossRefPubMed Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S et al (2002) Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 18:61–71CrossRefPubMed
22.
Zurück zum Zitat Sharma S, Kulk N, Nold MF, Graf R, Kim SH, Reinhardt D et al (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180:5477–5482CrossRefPubMed Sharma S, Kulk N, Nold MF, Graf R, Kim SH, Reinhardt D et al (2008) The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 180:5477–5482CrossRefPubMed
23.
Zurück zum Zitat Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA (2004) Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 381:503–510CrossRefPubMedPubMedCentral Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA (2004) Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 381:503–510CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB et al (2011) Interleukin 37 expression protects mice from colitis. PNAS 108(40):16711–16716CrossRefPubMedPubMedCentral McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB et al (2011) Interleukin 37 expression protects mice from colitis. PNAS 108(40):16711–16716CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Ballak DB, van Diepen JA, Moschen AR, Jansen HJ, Hijmans A, Groenhof GJ et al (2014) IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun 5:4711CrossRefPubMed Ballak DB, van Diepen JA, Moschen AR, Jansen HJ, Hijmans A, Groenhof GJ et al (2014) IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun 5:4711CrossRefPubMed
26.
Zurück zum Zitat Moretti S, Bozza S, Oikonomou V, Renga G, Casagrande A, Lannitti RG et al (2014) IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis. Plos Pathog 10(11), e1004462CrossRefPubMedPubMedCentral Moretti S, Bozza S, Oikonomou V, Renga G, Casagrande A, Lannitti RG et al (2014) IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis. Plos Pathog 10(11), e1004462CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y et al (2014) IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 12:69CrossRefPubMedPubMedCentral Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y et al (2014) IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 12:69CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Zhao PW, Jiang WG, Wang L (2014) Plasma levels of IL-37 and correlation with TNF-a, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 9, e95346CrossRefPubMedPubMedCentral Zhao PW, Jiang WG, Wang L (2014) Plasma levels of IL-37 and correlation with TNF-a, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One 9, e95346CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Scanu A, Oliviero F, Gruaz L, Sfriso P, Pozzuoli A, Frezzato F et al (2010) High-density lipoproteins down-regulate CCL2 production in human fibroblast like synoviocytes stimulated by urate crystals. Arthritis Res Ther 12:R23CrossRefPubMedPubMedCentral Scanu A, Oliviero F, Gruaz L, Sfriso P, Pozzuoli A, Frezzato F et al (2010) High-density lipoproteins down-regulate CCL2 production in human fibroblast like synoviocytes stimulated by urate crystals. Arthritis Res Ther 12:R23CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241CrossRefPubMed Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241CrossRefPubMed
31.
Zurück zum Zitat Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO (2004) Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 50:2273–2280CrossRefPubMed Yagnik DR, Evans BJ, Florey O, Mason JC, Landis RC, Haskard DO (2004) Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum 50:2273–2280CrossRefPubMed
Metadaten
Titel
IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response
verfasst von
Mei Zeng
Wantai Dang
Baofeng Chen
Yufeng Qing
Wenguang Xie
Mingcai Zhao
Jingguo Zhou
Publikationsdatum
07.11.2015
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 9/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3109-5

Weitere Artikel der Ausgabe 9/2016

Clinical Rheumatology 9/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.